Vaxcyte, Inc. ($PCVX)
Filing Information
| Accession Number | 0001813798-26-000021 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
6,750
Total Value
$139,550.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Ofc, COO | Common Stock | โ | Oct 1, 2026 | Exercise/Conversion | 2,250 | $5.35 | $12,037.50 | 147,685 | Direct | โ | View Details | |
EVP, Chief Scientific Ofc, COO | Common Stock | โ | Oct 1, 2026 | Sale | 2,155 | $56.65 | $122,089.37 | 145,530 | Direct | โ | View Details | |
EVP, Chief Scientific Ofc, COO | Common Stock | โ | Oct 1, 2026 | Sale | 95 | $57.09 | $5,423.93 | 145,435 | Direct | โ | View Details | |
EVP, Chief Scientific Ofc, COO | Stock Option (right to buy) | Derivative | Oct 1, 2026 | Exercise/Conversion | 2,250 | $0.00 | $0.00 | 64,398 | Direct | โ | View Details |